Position in INCY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$46,468,267
-$6,047,050 QoQ
Shares Held
493,713
-7.1% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WORLDQUANT MILLENNIUM ADVISORS LLC holds $237,388,644 across 14 Biotechnology names. INCY ranks #3 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
100,669 | $77,780,896 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
622,304 | $60,519,064 | |
| 3 | INCY |
Incyte Corp
This page
|
493,713 | $46,468,267 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
42,160 | $13,949,479 | |
| 5 | EXEL |
Exelixis, Inc.
|
236,324 | $10,135,936 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
202,420 | $5,607,034 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
214,587 | $4,669,413 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
23,677 | $4,476,136 |
All Filings in INCY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46,468,267 | 493,713 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $52,515,317 | 531,693 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,160,768 | 72,642 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,054,595 | 118,276 | Shares | Defined | 2025-08-14 | |
| 2024-06-30 | $24,736,051 | 408,051 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $31,907,244 | 560,071 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $62,445,659 | 994,516 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $41,944,659 | 726,063 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $23,589,015 | 378,940 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,682,662 | 203,164 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,400,540 | 79,688 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,631,546 | 129,525 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,343,163 | 136,148 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,812,012 | 85,772 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $21,370,336 | 291,149 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,633,678 | 125,526 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $14,536,906 | 172,791 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $15,944,280 | 196,189 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $17,064,519 | 196,189 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $17,606,000 | 196,189 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $20,202,202 | 194,308 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $27,765,154 | 379,150 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||